000 | 02006 a2200553 4500 | ||
---|---|---|---|
005 | 20250513215956.0 | ||
264 | 0 | _c20010108 | |
008 | 200101s 0 0 eng d | ||
022 | _a0263-6352 | ||
024 | 7 |
_a10.1097/00004872-200018080-00019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDevereux, R B | |
245 | 0 | 0 |
_aLeft ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension. _h[electronic resource] |
260 |
_bJournal of hypertension _cAug 2000 |
||
300 |
_a1129-38 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Rate _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xphysiopathology |
650 | 0 | 4 |
_aLosartan _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 |
_aOxygen Consumption _xphysiology |
650 | 0 | 4 | _aSex Characteristics |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVentricular Function, Left _xphysiology |
700 | 1 | _aRoman, M J | |
700 | 1 | _aPalmieri, V | |
700 | 1 | _aOkin, P M | |
700 | 1 | _aBoman, K | |
700 | 1 | _aGerdts, E | |
700 | 1 | _aNieminen, M S | |
700 | 1 | _aPapademetriou, V | |
700 | 1 | _aWachtell, K | |
700 | 1 | _aDahlöf, B | |
773 | 0 |
_tJournal of hypertension _gvol. 18 _gno. 8 _gp. 1129-38 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004872-200018080-00019 _zAvailable from publisher's website |
999 |
_c10902588 _d10902588 |